findmyKOL

Dragos Zanchi, MD

Basic profile

Tampa Bay Research Institute

ORCIDNone on fileNPI
RegionBrandon, FL · SoutheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Dragos Zanchi is a Respiratory physician affiliated with Tampa Bay Research Institute. OpenAlex indexes 7 publications with 564 citations (h-index 2).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

564citations

Total citations across indexed works.

2h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
65companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

311 Noland Dr
Brandon, FL 335115727

Telephone

813-654-8100

Registry record last updated 13 Dec 2010.

View the NPPES registry record

Industry payments

65 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    68.1%
    Corticosteroid28.8%
    Trelegy Ellipta36%Symbicort19%Fluticasone Propionate14%Breztri Aerosphere13%Breo Ellipta7%Breyna6%Budesonide-Formoterol Fumarate4%Mometasone Furoate1%Fluticasone-Vilanterol0%Dulera0%
    Part D<11 patients
    beta2-Adrenergic Agonist19.1%
    Albuterol Sulfate Hfa86%Ventolin Hfa14%Proair Respiclick1%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    9.4%
    Corticosteroid5.5%
    Prednisone100%
    Part D370 patients
    H2 blocker1.9%
    Famotidine100%
    Part D98 patients

    + 7 more classes in this area

  • Nervous system

    9%
    Nonergot Dopamine Agonist2.1%
    Pramipexole Dihydrochloride82%Ropinirole Hcl18%
    Part D78 patients
    Gabapentinoids1.9%
    Gabapentin100%
    Part D85 patients

    + 13 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”